MedCity News October 31, 2024
Dr. Belinda Birnbaum

For those who rely on these treatments, affordable medication access is a matter of health, freedom, and dignity, and their mechanisms and outcomes are non-partisan.

I frequently have conversations with my patients in their early sixties who are planning for retirement – an important part of which is transitioning from commercial insurance to Medicare. When making this switch, a common concern for my older patients is ensuring they can still access their medications to manage their rheumatological conditions comfortably and affordably.

Injectable biologic medications, like Enbrel, are a highly effective but expensive, life-changing treatment option for rheumatoid and psoriatic arthritis. However, many patients have often found these medications out of reach because of their high cost, and Medicare was...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Insurance, Medicare, Patient / Consumer, Physician, Provider
Medicare Accountable Care Organizations In 2023: Large Savings With Increasing Value-Based Programmatic Competition
Medicare Enrollment Trends in Four Charts
Innovation At CMS: Advancing A Person-Centered Health System
Drug Price Negotiation Requires Oversight To Protect Older Americans
Medicare Part D drug prices up nearly 100%

Share This Article